Oral Anticoagulation and Preventing Stent Thrombosis

14

description

Oral Anticoagulation and Preventing Stent Thrombosis. Unadjusted Kaplan-Meier Survival Curves for STEMI vs NSTEMI. ATLAS ACS 2—TIMI 51: Rivaroxaban. All-cause mortality, non-fatal MI, non-fatal stroke, and severe recurrent ischemia (%); a ll patients received ASA +/- clopidogrel. - PowerPoint PPT Presentation

Transcript of Oral Anticoagulation and Preventing Stent Thrombosis

Page 1: Oral Anticoagulation and Preventing Stent Thrombosis
Page 2: Oral Anticoagulation and Preventing Stent Thrombosis
Page 3: Oral Anticoagulation and Preventing Stent Thrombosis
Page 4: Oral Anticoagulation and Preventing Stent Thrombosis
Page 5: Oral Anticoagulation and Preventing Stent Thrombosis
Page 6: Oral Anticoagulation and Preventing Stent Thrombosis
Page 7: Oral Anticoagulation and Preventing Stent Thrombosis
Page 8: Oral Anticoagulation and Preventing Stent Thrombosis
Page 9: Oral Anticoagulation and Preventing Stent Thrombosis
Page 10: Oral Anticoagulation and Preventing Stent Thrombosis
Page 11: Oral Anticoagulation and Preventing Stent Thrombosis
Page 12: Oral Anticoagulation and Preventing Stent Thrombosis
Page 13: Oral Anticoagulation and Preventing Stent Thrombosis
Page 14: Oral Anticoagulation and Preventing Stent Thrombosis